GB0908006D0 - New crystal form - Google Patents

New crystal form

Info

Publication number
GB0908006D0
GB0908006D0 GBGB0908006.0A GB0908006A GB0908006D0 GB 0908006 D0 GB0908006 D0 GB 0908006D0 GB 0908006 A GB0908006 A GB 0908006A GB 0908006 D0 GB0908006 D0 GB 0908006D0
Authority
GB
United Kingdom
Prior art keywords
crystal form
new crystal
new
crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0908006.0A
Other versions
GB2469883A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GB0908006A priority Critical patent/GB2469883A/en
Publication of GB0908006D0 publication Critical patent/GB0908006D0/en
Publication of GB2469883A publication Critical patent/GB2469883A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
GB0908006A 2009-04-30 2009-04-30 Novel crystalline form of Prasugrel hydrogensulphate Withdrawn GB2469883A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0908006A GB2469883A (en) 2009-04-30 2009-04-30 Novel crystalline form of Prasugrel hydrogensulphate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0908006A GB2469883A (en) 2009-04-30 2009-04-30 Novel crystalline form of Prasugrel hydrogensulphate

Publications (2)

Publication Number Publication Date
GB0908006D0 true GB0908006D0 (en) 2009-06-24
GB2469883A GB2469883A (en) 2010-11-03

Family

ID=40833751

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0908006A Withdrawn GB2469883A (en) 2009-04-30 2009-04-30 Novel crystalline form of Prasugrel hydrogensulphate

Country Status (1)

Country Link
GB (1) GB2469883A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100692934B1 (en) 2000-12-25 2007-03-12 상꾜 가부시키가이샤 Medicinal compositions containing aspirin
TWI392681B (en) 2006-04-06 2013-04-11 Daiichi Sankyo Co Ltd Prasugrel with high purity and a method for preparing its acid addition salt
PL2448945T3 (en) 2010-04-08 2015-06-30 Teva Pharma Crystalline forms of prasugrel salts
US8603537B2 (en) 2012-04-02 2013-12-10 Egis Pharmaceuticals Plc Prasugrel containing quickly released stable oral pharmaceutical compositions
CN102977116B (en) * 2012-12-24 2014-12-03 天津大学 Amorphous prasugrel hydrogen sulfate and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI392681B (en) * 2006-04-06 2013-04-11 Daiichi Sankyo Co Ltd Prasugrel with high purity and a method for preparing its acid addition salt
EP2257556A1 (en) * 2008-02-06 2010-12-08 Helm AG Prasugrel salts with improved properties
WO2009129983A1 (en) * 2008-04-21 2009-10-29 Ratiopharm Gmbh Acid addition salts of prasugrel and pharmaceutical compositions comprising the same
DE602008002820D1 (en) * 2008-04-25 2010-11-11 Sandoz Ag Hydrogen sulfate of 2-acetoxy-5- (α-cyclopropylcarbonyl-2-fluorobenzyl) -4,5,6,7-tetrahydrothienoÄ3,2-cpyridine and its preparation
WO2010070677A2 (en) * 2008-12-15 2010-06-24 Glenmark Generics Limited A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
GB2469883A (en) 2010-11-03

Similar Documents

Publication Publication Date Title
HUS1800015I1 (en) Crystals
EP2457176A4 (en) Virtual-machine-based application-service provision
GB201103481D0 (en) No details
GB201016096D0 (en) No details
GB201016097D0 (en) No details
ZA201109437B (en) Novel azabicyclohexanes
ZA201105535B (en) Novel tricyanoborates
HK1146956A1 (en) Timepiece
GB0908006D0 (en) New crystal form
TWM390683U (en) Crystal decoration
GB0921296D0 (en) Display case
AU4926P (en) Bonscalib Scaevola aemula
AU4925P (en) Bonscawi Scaevola aemula
AU4924P (en) Bonscablue Scaevola aemula
AU4240P (en) Tuckerbox xTriticosecale
GB0920438D0 (en) Display
GB201021429D0 (en) Crystal structure
GB201006722D0 (en) Crystal structure
GB0904353D0 (en) Novel thiazolopyrimidines
HU0900605D0 (en) Crystal temple
GB0907959D0 (en) Easy line-eyeliner
GB0903381D0 (en) Display case
GB0900563D0 (en) New combination
GB0913256D0 (en) New use
GB0912567D0 (en) New use

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)